The biopharmaceutical company is screening patients for its randomized, double-blind, placebo-controlled U.S. study.
The drug is a proprietary combination antibiotic therapy in oral pill formulation. Researchers are looking for 240 patients in 50 clinical sites throughout the U.S., Canada and Israel.
More Articles on Gastroenterology:
Dr. Gurpreet Singh Joins Woodland Healthcare in California
7 Ways to Use Key Quality Metrics to Improve Gastroenterology Centers
Drs. Anthony Masciarelli, Renjy Vattasseril Join Cape Regional Medical Center’s ASC
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
